Imjudo & Imfinzi PMS
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Based on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci kwalifikujący się do leczenia lekami Imjudo i Imfinzi zgodnie ze wskazaniami zatwierdzonymi w Korei
- •Podpisana i datowana świadoma zgoda pacjenta lub jego opiekuna prawnego
✗ Disqualifies
- •Stosowanie leków poza zatwierdzonymi wskazaniami
- •Jednoczesny udział w innym badaniu klinicznym
Simplified criteria — AI translation
Trial details
- Last updated (source)
- October 5, 2026
- Sex
- No restrictions
Locations (6)
Research Site
Busan, South Korea
Research Site
Goyang, South Korea
Research Site
Seongnam, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Suwon, South Korea
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/6/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.